Know Exactly How Long Your Drug Patent Lasts in the GCC
Why the GCC Derails Pharma IP Teams That Know the U.S. System Cold There is a particular category of expensive […]
Know Exactly How Long Your Drug Patent Lasts in the GCC Read Post »
Read the Patent Trail: 4 Signals Your Competitor Is Extending a Drug’s Life
The Notice That Never Gets Sent Pharmaceutical companies do not issue press releases announcing lifecycle extension campaigns. They do not
Read the Patent Trail: 4 Signals Your Competitor Is Extending a Drug’s Life Read Post »
Time the Pitch: How Biopharma Packaging BizDev Teams Win by Aligning Child-Resistant Drug Packaging Campaigns with Drug Patent LOE Timeline
Executive Summary Most biopharma packaging sales reps knock on the wrong doors at the wrong time. They call on brand-side
GPT-Rosalind: What OpenAI’s Life Sciences Model Actually Does to Drug Development
On April 16, 2026, OpenAI did something it had never done before: it shipped a model designed not to chat,
GPT-Rosalind: What OpenAI’s Life Sciences Model Actually Does to Drug Development Read Post »
How to use patent expiry intelligence to reach biosimilar manufacturers at the moment their equipment decisions are live — not after they have already been made
When Humira lost its final U.S. patent protection in January 2023, more than thirty companies had already committed manufacturing capacity
European Drug Patents: Exactly How Long Protection Lasts — and Where It Breaks Down
The Answer Is Not 20 Years Every pharmaceutical patent lawyer knows the frustration. A client asks how long drug patent
European Drug Patents: Exactly How Long Protection Lasts — and Where It Breaks Down Read Post »
Slash drug discovery timelines with GPT-Rosalind
The pharmaceutical industry has been stuck in a productivity rut for decades. We spend billions of dollars and ten years
Slash drug discovery timelines with GPT-Rosalind Read Post »
Sell Before the Drug Patent Expiration Cliff: A guide for Commercial & Market Access Vendors using anticipated Loss of Exclusivity dates to offer contracting strategy support before generic entry
The 36-Month Window Most Vendors Miss Every year, billions of dollars in brand pharmaceutical revenue disappear within months of patent
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits
The pharmaceutical industry’s most elegant competitive weapon is also its most misunderstood. When a brand-name drug manufacturer launches its own
Authorized Generics: The Innovator’s Playbook for Diluting First-Filer Profits Read Post »
